🟢 Moleculin Biotech is trading 5.52% up today as broader equities rise

Moleculin Biotech is trading at $0.55 (+5.52%) as broader equities rise, supporting risk appetite.

• The Nasdaq Composite is up 0.62%, while the S&P 500 is up 0.46%.
• No verified August 13, 2026 company-specific announcement appears on Moleculin’s press-release page; its latest listed releases are dated July 31, 2026.
• The recent $9.3 million financing and MIRACLE trial updates are earlier catalysts, not new developments today.